JDD Webinars

Recognizing the Role of The Sebaceous Gland in Acne

By October 6, 2020April 22nd, 2021No Comments

Featured Article

Recognizing The Role of the Sebaceous Gland in Acne

The Role of Androgen Receptors in the Development and Management of Acne Vulgaris

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Faculty


Leon H. Kircik, MD

Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


James Q. Del Rosso, DO, FAOCD, FAAD

Research Director & Principal Investigator
JDR Dermatology Research
Thomas Dermatology
Las Vegas, Nevada

You May Also Like

Journal of Drugs in Dermatology JDD Article About The Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis. Arm and biceps of light skin pediatric patient with red or erythema atopic dermatitis before and after

The Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
When One Target Isn’t Enough — Dual Therapy Clears Refractory ADW An adolescent with persistent, widespread atopic dermatitis failed topical therapy and dupilumab, then achieved only partial control on upadacitinib…
Journal of Drugs in Dermatology JDD Article About Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

| Case Reports, Featured Articles, Latest News, Medical Derm, The Latest | No Comments
A Single‑Patient Signal That IL‑31 Blockade May Finally Tame The Relentless Itch Of Linear IgA Disease Linear IgA bullous dermatosis can be as much an itch disorder as a blistering…
Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of tinea versicolor among different skin tones

Tune In, Turn Up, and Celebrate — Happy National Podcast Day!

| Featured Articles, Featured Podcast, Latest News, The Latest | No Comments
Join JDD Podcast: Ask the Investigators as we celebrate almost a decade of dermatology insight with our trusted host, Dr. Adam Friedman. If you love learning with a smile, National…

Leave a Reply